Search

Suzanne Marie Noakes

Examiner (ID: 17824)

Most Active Art Unit
1656
Art Unit(s)
1656, 1653
Total Applications
1691
Issued Applications
1090
Pending Applications
193
Abandoned Applications
452

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17720437 [patent_doc_number] => 20220213157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => ELECTRICAL CONDUCTORS AND METHODS OF CONDUCTING IONS USING CALSEQUESTRIN PROTEINS [patent_app_type] => utility [patent_app_number] => 17/656221 [patent_app_country] => US [patent_app_date] => 2022-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11360 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17656221 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/656221
ELECTRICAL CONDUCTORS AND METHODS OF CONDUCTING IONS USING CALSEQUESTRIN PROTEINS Mar 22, 2022 Pending
Array ( [id] => 17852255 [patent_doc_number] => 20220282297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E [patent_app_type] => utility [patent_app_number] => 17/697043 [patent_app_country] => US [patent_app_date] => 2022-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14202 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697043 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/697043
BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E Mar 16, 2022 Pending
Array ( [id] => 17688109 [patent_doc_number] => 20220195401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => MODIFIED PIGGYBAC TRANSPOSASE POLYPEPTIDE, POLYNUCLEOTIDE ENCODING THEM, INTRODUCING CARRIER, KIT, METHOD OF INCORPORATING TARGET SEQUENCE INTO CELL GENOME, AND METHOD OF PRODUCING CELL [patent_app_type] => utility [patent_app_number] => 17/692857 [patent_app_country] => US [patent_app_date] => 2022-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692857 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/692857
MODIFIED PIGGYBAC TRANSPOSASE POLYPEPTIDE, POLYNUCLEOTIDE ENCODING THEM, INTRODUCING CARRIER, KIT, METHOD OF INCORPORATING TARGET SEQUENCE INTO CELL GENOME, AND METHOD OF PRODUCING CELL Mar 10, 2022 Pending
Array ( [id] => 17850528 [patent_doc_number] => 20220280569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS [patent_app_type] => utility [patent_app_number] => 17/691778 [patent_app_country] => US [patent_app_date] => 2022-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24835 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691778 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/691778
Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods Mar 9, 2022 Issued
Array ( [id] => 19778755 [patent_doc_number] => 12227779 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Modified DDAH polypeptides and their use to extracorporeally treat a patient's blood to reduce levels of ADMA [patent_app_type] => utility [patent_app_number] => 17/690657 [patent_app_country] => US [patent_app_date] => 2022-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 47629 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17690657 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/690657
Modified DDAH polypeptides and their use to extracorporeally treat a patient's blood to reduce levels of ADMA Mar 8, 2022 Issued
Array ( [id] => 17671020 [patent_doc_number] => 20220184187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => Combination treatment for atopic dermatitis [patent_app_type] => utility [patent_app_number] => 17/687789 [patent_app_country] => US [patent_app_date] => 2022-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687789 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/687789
Combination treatment for atopic dermatitis Mar 6, 2022 Abandoned
Array ( [id] => 17671020 [patent_doc_number] => 20220184187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => Combination treatment for atopic dermatitis [patent_app_type] => utility [patent_app_number] => 17/687789 [patent_app_country] => US [patent_app_date] => 2022-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687789 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/687789
Combination treatment for atopic dermatitis Mar 6, 2022 Abandoned
Array ( [id] => 17671020 [patent_doc_number] => 20220184187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => Combination treatment for atopic dermatitis [patent_app_type] => utility [patent_app_number] => 17/687789 [patent_app_country] => US [patent_app_date] => 2022-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687789 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/687789
Combination treatment for atopic dermatitis Mar 6, 2022 Abandoned
Array ( [id] => 19354324 [patent_doc_number] => 12054755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-06 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 17/683299 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 10164 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17683299 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/683299
None Feb 27, 2022 Issued
Array ( [id] => 18182839 [patent_doc_number] => 20230043569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => PRODUCTION OF GPP AND CBGA IN A METHYLOTROPHIC YEAST STRAIN [patent_app_type] => utility [patent_app_number] => 17/683123 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10418 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17683123 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/683123
PRODUCTION OF GPP AND CBGA IN A METHYLOTROPHIC YEAST STRAIN Feb 27, 2022 Pending
Array ( [id] => 17665506 [patent_doc_number] => 11359187 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-06-14 [patent_title] => Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells [patent_app_type] => utility [patent_app_number] => 17/680279 [patent_app_country] => US [patent_app_date] => 2022-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 33 [patent_no_of_words] => 26596 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 275 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680279 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/680279
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells Feb 23, 2022 Issued
Array ( [id] => 19043807 [patent_doc_number] => 11932894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-19 [patent_title] => Method for producing albicanol and/or drimenol [patent_app_type] => utility [patent_app_number] => 17/673465 [patent_app_country] => US [patent_app_date] => 2022-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20895 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673465 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/673465
Method for producing albicanol and/or drimenol Feb 15, 2022 Issued
Array ( [id] => 19043807 [patent_doc_number] => 11932894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-19 [patent_title] => Method for producing albicanol and/or drimenol [patent_app_type] => utility [patent_app_number] => 17/673465 [patent_app_country] => US [patent_app_date] => 2022-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20895 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673465 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/673465
Method for producing albicanol and/or drimenol Feb 15, 2022 Issued
Array ( [id] => 19609599 [patent_doc_number] => 12158471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-03 [patent_title] => Recombinant amebocyte lysate and uses thereof [patent_app_type] => utility [patent_app_number] => 17/650803 [patent_app_country] => US [patent_app_date] => 2022-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 18899 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650803 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/650803
Recombinant amebocyte lysate and uses thereof Feb 10, 2022 Issued
Array ( [id] => 17800405 [patent_doc_number] => 11414690 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-08-16 [patent_title] => Uridine diphosphate glycosyltransferase and use thereof [patent_app_type] => utility [patent_app_number] => 17/650591 [patent_app_country] => US [patent_app_date] => 2022-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10475 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650591 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/650591
Uridine diphosphate glycosyltransferase and use thereof Feb 9, 2022 Issued
Array ( [id] => 18955570 [patent_doc_number] => 20240043897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => SUBTILISIN VARIANTS AND THEIR USE [patent_app_type] => utility [patent_app_number] => 18/264101 [patent_app_country] => US [patent_app_date] => 2022-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16468 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264101 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/264101
SUBTILISIN VARIANTS AND THEIR USE Feb 8, 2022 Pending
Array ( [id] => 18955570 [patent_doc_number] => 20240043897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => SUBTILISIN VARIANTS AND THEIR USE [patent_app_type] => utility [patent_app_number] => 18/264101 [patent_app_country] => US [patent_app_date] => 2022-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16468 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264101 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/264101
SUBTILISIN VARIANTS AND THEIR USE Feb 8, 2022 Pending
Array ( [id] => 17627562 [patent_doc_number] => 20220162577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => METHODS AND COMPOSITIONS FOR REDUCING BACTERIAL LOAD IN TABACCO [patent_app_type] => utility [patent_app_number] => 17/665968 [patent_app_country] => US [patent_app_date] => 2022-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18595 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665968 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/665968
Methods and compositions for reducing bacterial load in tobacco Feb 6, 2022 Issued
Array ( [id] => 18658023 [patent_doc_number] => 20230303989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => OMNI-103 CRISPR NUCLEASE [patent_app_type] => utility [patent_app_number] => 18/006372 [patent_app_country] => US [patent_app_date] => 2022-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26229 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006372 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/006372
OMNI-103 CRISPR nuclease Feb 6, 2022 Issued
Array ( [id] => 18996182 [patent_doc_number] => 11913014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 17/665856 [patent_app_country] => US [patent_app_date] => 2022-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15708 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665856 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/665856
None Feb 6, 2022 Issued
Menu